Current Issue 3 February 2012, Vol. 586, No. 3

Issue Highlights

Research Letters with SDA

  • C-terminal residues of Oryza sativa GUN4 are required for the activation of the ChlH subunit of magnesium chelatase in chlorophyll synthesis
    3 February 2012(Vol. 586 | No. 3 | Pages 205-210)

    Shuaixiang Zhou, Artur Sawicki, Robert D. Willows, Meizhong Luo

  • FLU, a negative feedback regulator of tetrapyrrole biosynthesis, is physically linked to the final steps of the Mg++-branch of this pathway
    3 February 2012(Vol. 586 | No. 3 | Pages 211-216)

    Dominika Kauss, Sylvain Bischof, Sandro Steiner, Klaus Apel, Rasa Meskauskiene

  • Activation of macrophage-stimulating protein by human airway trypsin-like protease
    3 February 2012(Vol. 586 | No. 3 | Pages 217-221)

    Hiroshi Orikawa, Makiko Kawaguchi, Takashi Baba, Kenji Yorita, Sumio Sakoda, Hiroaki Kataoka

  • Overexpression of lalA, a paralog of labA, is capable of affecting both circadian gene expression and cell growth in the cyanobacterium Synechococcus elongatus PCC 7942
    27 January 2012

    Yasuhito Taniguchi, Tomoe Nishikawa, Takao Kondo, Tokitaka Oyama

  • Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells
    27 January 2012

    Yiwei Lin, Jian Wu, Hong Chen, Yeqing Mao, Yunfu Liu, Qiqi Mao, Kai Yang, Xiangyi Zheng, Liping Xie

  • LY294002 inhibits TLR3/4-mediated IFN-β production via inhibition of IRF3 activation with a PI3K-independent mechanism
    27 January 2012

    Wei Zhao, Jianni Qi, Lijuan Wang, Meng Zhang, Peng Wang, Chengjiang Gao

  • Phosphate homeostasis in the yeast Saccharomyces cerevisiae, the key role of the SPX domain-containing proteins
    27 January 2012

    David Secco, Chuang Wang, Huixia Shou, James Whelan

  • Novel assay with fluorescence-labeled PrP peptides for differentiating L-type atypical and classical BSEs, and scrapie
    27 January 2012

    Kazuo Kasai, Akiyoshi Hitara, Takafumi Ohyama, Kiyoshi Nokihara, Takashi Yokoyama, Shirou Mohri

  • View More Articles in Press...



On the Cover


Cover Image

More About FEBS

FEBS, since its inception in 1964, has promoted life sciences and supported scientists in Europe and elsewhere, and is one of the largest not-for-profit organizations in life sciences today. Among the offers to our members are participation in advance courses, the support of fellowships and participation in our annual Congress. All activities related to FEBS are financed by income generated by our four publications: FEBS Letters, FEBS Journal, Molecular Oncology, and FEBS OpenBio. As reader or author of papers in these journals, you contribute to our mission: To foster scientific excellence and promote science for society. Thank you for your support. For more information on FEBS, please visit www.febs.org.

Publishing Information

FEBS Letters is published by Elsevier BV on behalf of the Federation of European Biochemical Societies.



Access this journal onSciVerse ScienceDirect
Print or Share This Page

Announcements

FEBS Letters Structured Digital Abstracts Experiment

Protein interaction papers to have Structured Digital Summary

Read the Press Release for more details and explanation of this innovative experiment.

Past Announcements

Special Issues

      

Virtual Special Issues

FEBS Letters is proud to launch a new series of Virtual Special Issues which will highlight a collection of outstanding articles recently published in the journal, focusing on a selection of topics that we hope will be of general interest to our readers.